Search results
Results from the WOW.Com Content Network
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers.
When neurotechnology company Neuralink was founded by Musk in 2016, corporate filings listed Birchall as its chief executive, chief financial officer and president. [8] According to Bloomberg News, he is not involved in daily operations of the company and that his name was listed on the filings for legal convenience. [5]
Blindsight is an experimental medical device developed by Neuralink. [ 1 ] [ 2 ] It has received Breakthrough Device Designation from the US Food and Drugs Administration (FDA) . [ 3 ] [ 4 ]
Elon Reeve Musk was born on June 28, 1971, in Pretoria, South Africa's administrative capital. [2] [3] He is of British and Pennsylvania Dutch ancestry.[4] [5] His mother, Maye (née Haldeman), is a model and dietitian born in Saskatchewan, Canada, and raised in South Africa.
Rapoport was previously on the eight-member founding team at Elon Musk’s brain–computer interface company, Neuralink. Rapoport left Neuralink in 2018. [1] Rapoport, along with Michael Mager, an investor and business builder, and a team of experts in areas such as neuroscience, microfabrication and software launched Precision Neuroscience in ...
In 2016, Musk launched Neuralink with help from seven scientists and one engineer. Only two remain of the founding group—Musk and engineer DJ Seo. The goal of Neuralink is to develop brain ...
Özlem Türeci (Turkish pronunciation: [ˈœzlem ˈtyredʒi]; born 6 March 1967) is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. [2]